Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock.
Cutting-edge studies in the best international scientific publications, rounds of investment, licenses… despite saying goodbye to the EMA and the political instability of this last quarter of the year, the Catalan healthcare and life sciences sector has maintained its role as a global benchmark for this type of ecosystem.
The competitive grants from the European Research Council (ERC) have been recognizing research of excellence in Europe since 2007. Since then, research projects based in Catalonia have obtained 261 ERC grants, 77 of them in the healthcare and life sciences arena. In terms of number of grants per million inhabitants, Catalonia is ranked second among EU countries. In the last ERC Starting Grants call, 3 projects from the BioRegion of Catalonia were awarded: we’re getting into the lab with their leaders.